Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Patents
  • Published:

PATENTS

3D and 4D bioprinted human model patenting and the future of drug development

Nature Biotechnology volume 38, pages 689–694 (2020)Cite this article

Subjects

Bioprinted 3D and 4D tissues and organs are expected to revolutionize the biomedical field, eliminating the need for laboratory animals, but little is known about the future impacts of these technologies on drug development.

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Fig. 1: Networks of technology areas and patent assignees of bioprinting-related patents.
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

References

  1. Doke, S. K. & Dhawale, S. C. Saudi Pharm. J. 23, 223–229 (2015).

    Article  Google Scholar 

  2. Graham, M. L. & Prescott, M. J. Eur. J. Pharmacol. 759, 19–29 (2015).

    Article  CAS  Google Scholar 

  3. Cheluvappa, R., Scowen, P. & Eri, R. Pharmacol. Res. Perspect. 5, e00332 (2017).

    Article  Google Scholar 

  4. Fleetwood, G. et al. J. Am. Assoc. Lab. Anim. Sci. 54, 192–197 (2015).

    PubMed  PubMed Central  Google Scholar 

  5. Vanderburgh, J., Sterling, J. A. & Guelcher, S. A. Ann. Biomed. Eng. 45, 164–179 (2017).

    Article  Google Scholar 

  6. Goh, J.-Y. et al. Toxicol. Res. 4, 1297–1307 (2015).

    Article  CAS  Google Scholar 

  7. Stokes, W. S. Hum. Exp. Toxicol. 34, 1297–1303 (2015).

    Article  CAS  Google Scholar 

  8. Groeber, F. et al. ALTEX 33, 415–422 (2016).

    PubMed  Google Scholar 

  9. Burden, N. et al. Nano Today 12, 10–13 (2017).

    Article  CAS  Google Scholar 

  10. Löwa, A., Jevtić, M., Gorreja, F. & Hedtrich, S. Exp. Dermatol. 27, 476–483 (2018).

    Article  Google Scholar 

  11. Rosania, K. Lab. Anim. 42, 189–190 (2013).

    Article  Google Scholar 

  12. Kim, K., Park, H. & Lim, K.-M. Toxicol. Res. 31, 97–104 (2015).

    Article  CAS  Google Scholar 

  13. Ford, K. A. ILAR J. 57, 226–233 (2016).

    Article  CAS  Google Scholar 

  14. Atala, A. & Yoo, J. J. Essentials of 3D Biofabrication and Translation (Elsevier Science, 2015).

  15. Peng, W. et al. Acta Biomater. 57, 26–46 (2017).

    Article  CAS  Google Scholar 

  16. Brown, G. E. & Khetani, S. R. Philos. T. R. Soc. B 373, e2017.0225 (2018).

    Article  Google Scholar 

  17. Ahn, S. H. et al. J. Tissue Eng. Regen. Med. 13, 663–676 (2016).

    Article  CAS  Google Scholar 

  18. Gao, G. & Cui, X. Biotechnol. Lett. 38, 203–211 (2016).

    Article  CAS  Google Scholar 

  19. Huang, Y. et al. Biotechnol. J. 12, 1600734 (2017).

    Article  Google Scholar 

  20. Hunsberger, J. et al. Curr. Stem Cell Rep. 2, 118–127 (2016).

    Article  CAS  Google Scholar 

  21. Yang, G. H., Yeo, M., Koo, Y. W. & Kim, G. H. Macromol. Biosci. 19, e1800441 (2019).

    Article  Google Scholar 

  22. Ashammakhi, N. et al. Biotechnol. J. 13, e1800148 (2018).

    Article  Google Scholar 

  23. Mammadov, E. Cyprus J. Med. Sci. 3, 186–188 (2018).

    Article  Google Scholar 

  24. Moldovan, N. I. J. Cell. Mol. Med. 22, 2964–2969, https://doi.org/10.1111/jcmm.13598 (2018).

    Article  Google Scholar 

  25. Awad, A., Trenfield, S. J., Goyanes, A., Gaisford, S. & Basit, A. W. Drug Discov. Today 23, 1547–1555 (2018).

    Article  CAS  Google Scholar 

  26. Charbe, N., McCarron, P. A. & Tambuwala, M. M. World J. Clin. Oncol. 8, 21–36 (2017).

    Article  Google Scholar 

  27. Mazzocchi, A., Soker, S. & Skardal, A. Appl. Phys. Rev. 6, 11302 (2019).

    Article  Google Scholar 

  28. Drăgănescu, D. Farmacia 67, 1–9 (2019).

    Article  Google Scholar 

  29. Lerman, M. J. et al. Appl. Phys. Rev. 5, 41109 (2018).

    Article  Google Scholar 

  30. Kačarević, Ž. P. et al. Materials (Basel) 11, 2199 (2018).

    Article  Google Scholar 

  31. Jang, J., Yi, H.-G. & Cho, D.-W. ACS Biomater. Sci. Eng. 2, 1722–1731 (2016).

    Article  CAS  Google Scholar 

  32. European Parliament. Regulation (eu) no 575/2013 of the European Parliament and of the Council. OJEU 176, 1–337 (2013).

    Google Scholar 

  33. USDA. Animal Welfare Act and Animal Welfare Regulations (USDA, 2017).

  34. Frank, J. Struct. Change Econ. Dyn. 16, 557–575 (2005).

    Article  Google Scholar 

  35. Herrmann, K. (ed.). Animal Experimentation: Working Towards a Paradigm Change (Brill, 2019).

  36. Ngo, T. D. et al. Compos. B Eng. 143, 172–196 (2018).

    Article  CAS  Google Scholar 

  37. Ma, X. et al. Adv. Drug Deliv. Rev. 132, 235–251 (2018).

    Article  CAS  Google Scholar 

  38. Bhanu, P. C. H. Transl. Biomed. 7, 4 (2016); https://doi.org/10.2167/2172-0479.100099

  39. Peng, W., Unutmaz, D. & Ozbolat, I. T. Trends Biotechnol. 34, 722–732 (2016).

    Article  CAS  Google Scholar 

  40. Mohammadi, M. H., Obregón, R., Ahadian, S., Ramón-Azcón, J. & Radisic, M. Curr. Pharm. Des. 23, 2991–3004 (2017).

    Article  CAS  Google Scholar 

  41. Haque, S., Md, S., Whittaker, M. & Kaminskas, L. M. Curr. Pharm. Des. 24, 5072–5080 (2018).

    Article  CAS  Google Scholar 

Download references

Acknowledgements

The authors thank the Center for Strategic Studies of Oswaldo Cruz Foundation (CEE-Fiocruz) for institutional support and the respondents who participated in this study. This study was supported by research funds from Inova Fiocruz/Fundação Oswaldo Cruz.

Author information

Authors and Affiliations

  1. Oswaldo Cruz Foundation, Rio de Janeiro, Brazil

    Fabio Mota, Luiza Braga, Leonardo Rocha & Bernardo Cabral

Authors
  1. Fabio Mota
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Luiza Braga
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Leonardo Rocha
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Bernardo Cabral
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

F.M. designed, planned, coordinated and analyzed the work and revised the paper. L.B. reviewed the literature, interpreted results and wrote the paper. L.R. analyzed and evaluated statistical data and graphs and described results. B.C. organized and conducted the survey protocol and revised the final paper. All authors approved the submitted final version.

Corresponding author

Correspondence to Fabio Mota.

Ethics declarations

Competing interests

The authors declare no competing interests.

Supplementary information

Supplementary Information

Supplementary Tables 1 and 2 and Appendixes A and B

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Mota, F., Braga, L., Rocha, L. et al. 3D and 4D bioprinted human model patenting and the future of drug development. Nat Biotechnol 38, 689–694 (2020). https://doi.org/10.1038/s41587-020-0540-1

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41587-020-0540-1

This article is cited by

Search

Advanced search

Quick links

Nature Briefing: Translational Research

Sign up for the Nature Briefing: Translational Research newsletter — top stories in biotechnology, drug discovery and pharma.

Get what matters in translational research, free to your inbox weekly. Sign up for Nature Briefing: Translational Research